Form 4: Evolent Health Executive Aammaad Shams Reports Stock Transactions
SEC Form 4
Aammaad Shams, Chief Accounting Officer of Evolent Health, Inc., reports acquisition and disposal of Class A Common Stock and restricted stock units.
Summary
- On March 1, 2024, Aammaad Shams, Chief Accounting Officer of Evolent Health, Inc., acquired 7,491 shares of Class A Common Stock at $0, resulting in a total of 57,515 shares beneficially owned.
- On the same day, Mr. Shams disposed of 2,569 shares of Class A Common Stock at $34.41, leaving him with 54,946 shares.
- The acquisition represents restricted stock units granted under the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
- These securities vest at a rate of 34% on March 1, 2025, and 33% on March 1, 2026, and March 1, 2027.
- The disposal represents shares withheld to satisfy tax obligations upon vesting of restricted stock units.
Sentiment
Score: 6
Explanation: Neutral sentiment. The filing reflects routine stock transactions related to executive compensation. There's no indication of unusual activity or significant concerns.
Positives
- The acquisition of restricted stock units indicates confidence in the company's future performance.
Negatives
- The disposal of shares to cover tax obligations could be perceived as a minor negative, although it's a standard practice.
Future Outlook
The vesting schedule of the restricted stock units suggests a multi-year commitment from the executive.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. This filing indicates standard compensation practices.
Comparison to Industry Standards
- Stock-based compensation is a common practice in the healthcare technology industry, used to align executive incentives with shareholder value.
- Companies like Cerner (now Oracle Health) and UnitedHealth Group also utilize restricted stock units as part of their executive compensation packages.
- The vesting schedule is typical for such grants, encouraging long-term commitment.
Stakeholder Impact
- The stock transactions have a minimal direct impact on shareholders, employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of stock acquisition and disposal. |
| 03/01/2025 | 34% of restricted stock units vest. |
| 03/01/2026 | 33% of restricted stock units vest. |
| 03/01/2027 | 33% of restricted stock units vest. |
| 03/05/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.